Literature DB >> 20521994

Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases.

Scott Becka1, Peng Zhang, Sonya E L Craig, David T Lodowski, Zhenghe Wang, Susann M Brady-Kalnay.   

Abstract

Receptor protein tyrosine phosphatases (RPTPs) have cell adhesion molecule-like extracellular domains coupled to cytoplasmic tyrosine phosphatase domains. PTPmu is the prototypical member of the type IIb subfamily of RPTPs, which includes PTPrho, PTPkappa, and PCP-2. The authors performed the first comprehensive analysis of the subfamily in one system, examining adhesion and antibody recognition. The authors evaluated if antibodies that they developed to detect PTPmu also recognized other subfamily members. Notably, each antibody recognizes distinct subsets of type IIb RPTPs. PTPmu, PTPrho, and PTPkappa have all been shown to mediate cell-cell aggregation, and prior work with PCP-2 indicated that it can mediate bead aggregation in vitro. This study reveals that PCP-2 is unique among the type IIb RPTPs in that it does not mediate cell-cell aggregation via homophilic binding. The authors conclude from these experiments that PCP-2 is likely to have a distinct biological function other than cell-cell aggregation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521994      PMCID: PMC3337334          DOI: 10.3109/15419061.2010.487957

Source DB:  PubMed          Journal:  Cell Commun Adhes        ISSN: 1543-5180


  27 in total

1.  The conserved immunoglobulin domain controls the subcellular localization of the homophilic adhesion receptor protein-tyrosine phosphatase mu.

Authors:  Robert L Del Vecchio; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

2.  The receptor protein-tyrosine phosphatase PTPmu interacts with IQGAP1.

Authors:  Polly J Phillips-Mason; Theresa J Gates; Denice L Major; David B Sacks; Susann M Brady-Kalnay
Journal:  J Biol Chem       Date:  2005-12-27       Impact factor: 5.157

Review 3.  The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin.

Authors:  Jack Lilien; Janne Balsamo
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors.

Authors:  J Cheng; K Wu; M Armanini; N O'Rourke; D Dowbenko; L A Lasky
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

5.  Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain.

Authors:  G C Zondag; G M Koningstein; Y P Jiang; J Sap; W H Moolenaar; M F Gebbink
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

6.  Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase.

Authors:  M F Gebbink; G C Zondag; R W Wubbolts; R L Beijersbergen; I van Etten; W H Moolenaar
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

7.  Identification of the homophilic binding site of the receptor protein tyrosine phosphatase PTP mu.

Authors:  S M Brady-Kalnay; N K Tonks
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

8.  Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family.

Authors:  H Wang; Z Lian; M M Lerch; Z Chen; W Xie; A Ullrich
Journal:  Oncogene       Date:  1996-06-20       Impact factor: 9.867

9.  Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion.

Authors:  Alexandru Radu Aricescu; Wai-Ching Hon; Christian Siebold; Weixian Lu; Philip Anton van der Merwe; Edith Yvonne Jones
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

10.  Homophilic binding of PTP mu, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation.

Authors:  S M Brady-Kalnay; A J Flint; N K Tonks
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

View more
  11 in total

Review 1.  Tumour suppressor function of protein tyrosine phosphatase receptor-T.

Authors:  Anthony Scott; Zhenghe Wang
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

Review 2.  Tumor-derived extracellular fragments of receptor protein tyrosine phosphatases (RPTPs) as cancer molecular diagnostic tools.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

Review 3.  Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.

Authors:  Alma N Mohebiany; Roman M Nikolaienko; Samuel Bouyain; Sheila Harroch
Journal:  FEBS J       Date:  2012-07-05       Impact factor: 5.542

Review 4.  Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.

Authors:  Sonya E L Craig; Susann M Brady-Kalnay
Journal:  Semin Cell Dev Biol       Date:  2014-09-16       Impact factor: 7.727

Review 5.  Receptor protein tyrosine phosphatases and cancer: new insights from structural biology.

Authors:  Roman M Nikolaienko; Boadi Agyekum; Samuel Bouyain
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

Review 6.  Genetic alterations of protein tyrosine phosphatases in human cancers.

Authors:  S Zhao; D Sedwick; Z Wang
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

7.  The receptor PTPRU is a redox sensitive pseudophosphatase.

Authors:  Iain M Hay; Gareth W Fearnley; Pablo Rios; Maja Köhn; Hayley J Sharpe; Janet E Deane
Journal:  Nat Commun       Date:  2020-06-26       Impact factor: 14.919

8.  Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.

Authors:  Ping-Hui Sun; Lin Ye; Malcolm D Mason; Wen G Jiang
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

9.  Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis.

Authors:  Yiqing Zhao; Anthony Scott; Peng Zhang; Yujun Hao; Xiujing Feng; Saigopal Somasundaram; Ahmad M Khalil; Joseph Willis; Zhenghe Wang
Journal:  Oncotarget       Date:  2017-07-25

10.  PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.

Authors:  Hung-Chih Hsu; Nina Lapke; Shu-Jen Chen; Yen-Jung Lu; Ren-Shiang Jhou; Chien-Yuh Yeh; Wen-Sy Tsai; Hsin-Yuan Hung; Jason Chia-Hsun Hsieh; Tsai-Sheng Yang; Tan Kien Thiam; Jeng-Fu You
Journal:  Cancers (Basel)       Date:  2018-09-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.